COMMUNIQUÉS West-GlobeNewswire

Anthera Pharmaceuticals Announces Appointment of Patrick Murphy as Senior Vice President, Manufacturing

03/01/2018 - 14:30

HAYWARD, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ) today announced the appointment of Patrick Murphy as Senior Vice President, Manufacturing. Patrick brings over 35 years of [...]

Zosano Pharma Announces Notice of Allowance for a U.S. Patent Application Covering M207 as an Acute Treatment for Migraine

03/01/2018 - 14:30

FREMONT, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corp. (NASDAQ: ZSAN ) (“Zosano” or the “Company”) a clinical stage biopharmaceutical company focused on providing rapid systemic administration of [...]

Avinger Announces Treatment of First Patients Globally With Next Generation Pantheris

03/01/2018 - 14:30

REDWOOD CITY, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), announced that Arne Schwindt, M.D., a vascular [...]

Orion Corporation: Managers' transactions - Ylppö Jukka

03/01/2018 - 14:11

ORION CORPORATION MANAGERS' TRANSACTIONS 03 JANUARY 2018 at 15.10 EET Orion Corporation: Managers' transactions - Ylppö Jukka Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No [...]

Altimmune Elects Mitchel Sayare, Ph.D. as Chairman of its Board of Directors

03/01/2018 - 14:00

Current Chairman, David Drutz, M.D., remains Chairman of Compensation Committee and Member of the Board GAITHERSBURG, Md., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT ), a clinical-stage [...]

Diffusion Pharmaceuticals to Present at the 10th Annual Biotech Showcase™ Conference

03/01/2018 - 14:00

CHARLOTTESVILLE, Va., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN ) (“Diffusion” or “the Company”), a clinical-stage biotechnology company focused on extending the life expectancy of [...]

Jounce Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference

03/01/2018 - 14:00

CAMBRIDGE, Mass., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE ), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers [...]

BioSig Technologies Appoints New Chief Financial Officer to Facilitate Growth Trajectory

03/01/2018 - 14:00

Santa Monica, CA, Jan. 03, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]

ClearCorrect’s Flex and Unlimited pricing now available in Canada

03/01/2018 - 14:00

ROUND ROCK, Texas, Jan. 03, 2018 (GLOBE NEWSWIRE) -- ClearCorrect, LLC, a leading manufacturer of clear aligners, released their Flex ™ and Unlimited ™ pricing options to dentists and orthodontists in Canada on January [...]

Foamix Names Mr. David Domzalski as a Member of the Board of Foamix Pharmaceuticals

03/01/2018 - 14:00

REHOVOT, Israel and BRIDGEWATER, N.J., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX ) (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and [...]

Albireo Announces Royalty Monetization Agreement with HealthCare Royalty Partners for Elobixibat in Japan

03/01/2018 - 14:00

— Albireo subsidiary eligible to receive up to $60 million under agreement — — Decision on Japanese New Drug Application for elobixibat expected in first half of 2018 — BOSTON, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Albireo [...]

BeyondSpring Appoints Life Sciences Veteran Patrick Fabbio to Board of Directors as an Independent Member

03/01/2018 - 14:00

NEW YORK, Jan. 03, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI ), a global clinical stage biopharmaceutical company focused on the development and commercialization of innovative cancer therapies, today [...]

PositiveID’s ExcitePCR Subsidiary to Present and Exhibit at the Seed Central Tech Showcase on January 11th

03/01/2018 - 14:00

Seed Central Showcase facilitates research collaboration between the seed and agbiotech industry and UC Davis to bring science to market faster Kimothy Smith, DVM, EVP and Chief Science Officer of ExcitePCR, will [...]

Emerald Health Announces $15 Million Prospectus Sale; Concurrent Secondary Sale

03/01/2018 - 14:00

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VICTORIA, British Columbia, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF [...]

Inovalon Announces Charitable Giving for 2017

03/01/2018 - 13:55

BOWIE, Md., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV ), a leading technology company providing advanced, cloud-based platforms empowering a data-driven transformation from volume-based to value-based [...]

Zealand Pharma major shareholder announcement: Wellington Management Group LLP, U.S.

03/01/2018 - 13:46

Company announcement - No.1/ 2018 Zealand Pharma major shareholder announcement: Wellington Management Group LLP, U.S. Copenhagen, January 3, 2018 - Zealand Pharma announces that it has received information from [...]

Mateon Therapeutics to Present at the 2018 Biotech Showcase

03/01/2018 - 13:30

SOUTH SAN FRANCISCO, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQX:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications, today [...]

Actinium Pharmaceuticals to Present at Biotech Showcase™ 2018 and Participate in Partnering Sessions

03/01/2018 - 13:30

Actinium scheduled to present on Monday, January 8, 2018 at 10:00 AM PT NEW YORK, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) ("Actinium" or "the Company") announced today that [...]

Checkpoint Therapeutics to Present at Biotech Showcase™ 2018

03/01/2018 - 13:30

NEW YORK, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT ), a Fortress Biotech (NASDAQ: FBIO ) company, today announced that President and Chief Executive Officer James F. [...]